393 related articles for article (PubMed ID: 30047028)
1. Challenges of NK cell-based immunotherapy in the new era.
Fang F; Xiao W; Tian Z
Front Med; 2018 Aug; 12(4):440-450. PubMed ID: 30047028
[TBL] [Abstract][Full Text] [Related]
2. Cancer Immunotherapy Based on Natural Killer Cells: Current Progress and New Opportunities.
Hu W; Wang G; Huang D; Sui M; Xu Y
Front Immunol; 2019; 10():1205. PubMed ID: 31214177
[TBL] [Abstract][Full Text] [Related]
3. NK cell-based immunotherapy for cancer.
Fang F; Xiao W; Tian Z
Semin Immunol; 2017 Jun; 31():37-54. PubMed ID: 28838796
[TBL] [Abstract][Full Text] [Related]
4. Boosting Natural Killer Cell-Based Immunotherapy with Anticancer Drugs: a Perspective.
Cifaldi L; Locatelli F; Marasco E; Moretta L; Pistoia V
Trends Mol Med; 2017 Dec; 23(12):1156-1175. PubMed ID: 29133133
[TBL] [Abstract][Full Text] [Related]
5. Reformation in chimeric antigen receptor based cancer immunotherapy: Redirecting natural killer cell.
Lin C; Zhang J
Biochim Biophys Acta Rev Cancer; 2018 Apr; 1869(2):200-215. PubMed ID: 29378229
[TBL] [Abstract][Full Text] [Related]
6. Improving efficacy of cancer immunotherapy by genetic modification of natural killer cells.
Burga RA; Nguyen T; Zulovich J; Madonna S; Ylisastigui L; Fernandes R; Yvon E
Cytotherapy; 2016 Nov; 18(11):1410-1421. PubMed ID: 27421740
[TBL] [Abstract][Full Text] [Related]
7. Improving natural killer cell cancer immunotherapy.
Berrien-Elliott MM; Romee R; Fehniger TA
Curr Opin Organ Transplant; 2015 Dec; 20(6):671-80. PubMed ID: 26414502
[TBL] [Abstract][Full Text] [Related]
8. Targeting Natural Killer Cells for Tumor Immunotherapy.
Zhang C; Hu Y; Shi C
Front Immunol; 2020; 11():60. PubMed ID: 32140153
[TBL] [Abstract][Full Text] [Related]
9. Natural Killer Cells: Angels and Devils for Immunotherapy.
Martín-Antonio B; Suñe G; Perez-Amill L; Castella M; Urbano-Ispizua A
Int J Mol Sci; 2017 Aug; 18(9):. PubMed ID: 28850071
[TBL] [Abstract][Full Text] [Related]
10. A New Ex Vivo Method for Effective Expansion and Activation of Human Natural Killer Cells for Anti-Tumor Immunotherapy.
Yang H; Tang R; Li J; Liu Y; Ye L; Shao D; Jin M; Huang Q; Shi J
Cell Biochem Biophys; 2015 Dec; 73(3):723-9. PubMed ID: 27259316
[TBL] [Abstract][Full Text] [Related]
11. NK cell-based immunotherapy for malignant diseases.
Cheng M; Chen Y; Xiao W; Sun R; Tian Z
Cell Mol Immunol; 2013 May; 10(3):230-52. PubMed ID: 23604045
[TBL] [Abstract][Full Text] [Related]
12. [Natural killer (NK) cell and immunotherapy].
Iino T; Takaishi S
Nihon Rinsho; 2017 Feb; 75(2):306-311. PubMed ID: 30562869
[TBL] [Abstract][Full Text] [Related]
13. The rise of human stem cell-derived natural killer cells for cancer immunotherapy.
Wang K; Han Y; Cho WC; Zhu H
Expert Opin Biol Ther; 2019 Feb; 19(2):141-148. PubMed ID: 30583701
[TBL] [Abstract][Full Text] [Related]
14. Natural killer cells as a promising therapeutic target for cancer immunotherapy.
Kim N; Lee HH; Lee HJ; Choi WS; Lee J; Kim HS
Arch Pharm Res; 2019 Jul; 42(7):591-606. PubMed ID: 30895524
[TBL] [Abstract][Full Text] [Related]
15. NK cell-based cancer immunotherapy: from basic biology to clinical application.
Li Y; Yin J; Li T; Huang S; Yan H; Leavenworth J; Wang X
Sci China Life Sci; 2015 Dec; 58(12):1233-45. PubMed ID: 26588912
[TBL] [Abstract][Full Text] [Related]
16. Expansion of natural killer (NK) and natural killer-like T (NKT)-cell populations derived from patients with B-chronic lymphocytic leukemia (B-CLL): a potential source for cellular immunotherapy.
Guven H; Gilljam M; Chambers BJ; Ljunggren HG; Christensson B; Kimby E; Dilber MS
Leukemia; 2003 Oct; 17(10):1973-80. PubMed ID: 14513047
[TBL] [Abstract][Full Text] [Related]
17. Adoptive transfer of osteoclast-expanded natural killer cells for immunotherapy targeting cancer stem-like cells in humanized mice.
Kozlowska AK; Kaur K; Topchyan P; Jewett A
Cancer Immunol Immunother; 2016 Jul; 65(7):835-45. PubMed ID: 27034236
[TBL] [Abstract][Full Text] [Related]
18. Natural killer cell engineering - a new hope for cancer immunotherapy.
Lin CY; Gobius I; Souza-Fonseca-Guimaraes F
Semin Hematol; 2020 Oct; 57(4):194-200. PubMed ID: 33256912
[TBL] [Abstract][Full Text] [Related]
19. Editorial: Molecular Strategies Aimed to Boost NK Cell-Based Immunotherapy of Cancer.
Cifaldi L; Di Santo J; Olive D
Front Immunol; 2020; 11():1132. PubMed ID: 32612604
[No Abstract] [Full Text] [Related]
20. Killers 2.0: NK cell therapies at the forefront of cancer control.
Hodgins JJ; Khan ST; Park MM; Auer RC; Ardolino M
J Clin Invest; 2019 Sep; 129(9):3499-3510. PubMed ID: 31478911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
